Patent classifications
C12Y301/27004
Biomarkers for the early detection of breast cancer
The present invention provides reagents and methods for breast cancer detection.
Biomarkers for the early detection of breast cancer
The present invention provides reagents and methods for breast cancer detection.
RNA AFFINITY PURIFICATION
Provided herein, in some embodiments, are methods of purifying a nucleic acid preparation. The methods may comprise contacting a nucleic acid preparation comprising messenger ribonucleic acid with an RNase III enzyme that is immobilized on a solid support and binds to double-stranded RNA contaminants.
RNA affinity purification
Provided herein, in some embodiments, are methods of purifying a nucleic acid preparation. The methods may comprise contacting a nucleic acid preparation comprising messenger ribonucleic acid with an RNase III enzyme that is immobilized on a solid support and binds to double-stranded RNA contaminants.
Biomarkers for the early detection of breast cancer
The present invention provides reagents and methods for breast cancer detection.
Biomarkers for the early detection of breast cancer
The present invention provides reagents and methods for breast cancer detection.
RNA AFFINITY PURIFICATION
Provided herein, in some embodiments, are methods of purifying a nucleic acid preparation. The methods may comprise contacting a nucleic acid preparation comprising messenger ribonucleic acid with an RNase III enzyme that is immobilized on a solid support and binds to double-stranded RNA contaminants.
Biomarkers for the early detection of breast cancer
The present invention provides reagents and methods for breast cancer detection.
Biomarkers for the early detection of breast cancer
The present invention provides reagents and methods for breast cancer detection.
Biomarkers for the early detection of breast cancer
The present invention provides reagents and methods for breast cancer detection.